Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An unusual malignant tumor that arises from the prostate gland. It is characterized by the presence of glandular elements and a cellular stroma that exhibits mitotic activity and nuclear atypia.
No clinical trials have been registered for malignant prostate phyllodes tumor.
4 publications have been identified in PubMed for malignant prostate phyllodes tumor. Research spans Case Report / Case Series (100%).
Lian H (2026). [PMID: 41756326](https://pubmed.ncbi.nlm.nih.gov/41756326/). *Frontiers in oncology*. [Case Report / Case Series]
Ciccotosto J (2026). [PMID: 42244344](https://pubmed.ncbi.nlm.nih.gov/42244344/). *Vet Radiol Ultrasound*. [Case Report / Case Series]
Liu Y (2025). [PMID: 40297816](https://pubmed.ncbi.nlm.nih.gov/40297816/). *Frontiers in oncology*. [Case Report / Case Series]
Wada R (2024). [PMID: 38978976](https://pubmed.ncbi.nlm.nih.gov/38978976/). *Molecular and clinical oncology*. [Case Report / Case Series]
Data assembled from 2 of 12 sources · Last updated Sep 19, 2026, 7:48 AM UTC
AI-curated news mentioning malignant prostate phyllodes tumor
Updated Aug 4, 2026
A recent study highlights the competing risks of cardiovascular and tumor-specific mortality in patients with malignant phyllodes tumor. This research underscores the need for comprehensive management strategies in this rare tumor type.